Articles

Breast cancer statistics 2024

Angela N Giaquinto , Hyuna Sung , Lisa A Newman , et al CA Cancer J Clin. 2024 Nov-Dec;74(6):477-495

Breast cancer incidence continued an upward trend, rising by 1% annually during 2012-2021, largely confined to localized-stage and hormone receptor-positive disease. A steeper increase in women younger than 50 years (1.4% annually) versus 50 years and older (0.7%) overall was only significant among White women. Asian A... Read More

15 Apr, 2026

Global burden, trends, and attributable risk factors of women's cancers with projection to 2050: Results from the GLOBOCAN 2022 and global burden of disease study 2021

Tingting Wei , Yunhai Li , Ze Zhang , et al. Eur J Surg Oncol. 2026 Mar 7;52(5):111742

Women's cancers pose a significant global health burden, with pronounced geographical and age-related disparities. Targeting modifiable risk factors and enhancing healthcare access, especially in low-SDI regions, is essential to reducing the worldwide burden of women's cancers. In 2022, there were 3.7 million new cases... Read More

15 Apr, 2026

The global epidemic of early-onset cancer: nature, nurture, or both?

S. Ogino and T. Ugai. Annals of Oncol;.35(12) 1071-1073. 2024

The incidence of early-onset cancer (EOC) diagnosed in individuals under the age of 50 has been increasing worldwide, which may be just the tip of the iceberg of larger emerging issues, including the rise of various chronic diseases across multiple generations. While this phenomenon was first recognized in colorectal c... Read More

15 Apr, 2026

Trends in the disease burden of early-onset cancers in China from 1990 to 2021: a systematic analysis of the 2021 Global Burden of Disease study

Jicun Zhu, Tiandong Li, Jiajun Chen, et al. BMC Cancer. 2025 Jul 12;25(1):1168

In recent years, the incidence of early-onset cancers among individuals under 50 years of age has been on the rise. From 1990 to 2021, the incidence rate of all early-onset cancers in China increased by 150.72 per 100,000, while the mortality and disability-adjusted life years (DALY) rates decreased by 4.30 per 100,000... Read More

15 Apr, 2026

The Economic Burden of Lung Cancer in Low- And Lower-Middle-Income Countries: A Systematic Review

Elyesa Ünal, Elena Goodchild, Volker Winkler, et al. Arch Public Health. 2025 Oct 13;83(1):243

Lung Cancer is one of the four most frequent malignant neoplasms in the world, and first in mortality. In 2020, lung cancer resulted in roughly 1.8 million deaths globally. Lung cancer is a major public health problem in low and lower-middle income countries, where high rates of tobacco smoking, environmental pollution... Read More

15 Apr, 2026

A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening

Stephen Lam,David R. Baldwin, Anand Devaraj, et al. Journal of Thoracic Oncology Vol. 21 No. 2: 235–252

In the past two decades, lung cancer screening (LCS) with low-dose computed tomography (LDCT) has emerged as one of the most effective strategies for reducing lung cancer mortality. Landmark trials, including NLST and NELSON, demonstrated mortality reductions exceeding 20%, establishing LDCT as the standard of care for... Read More

15 Apr, 2026

Initial-Care Medical and Prescription Costs for Incident Metastatic versus Nonmetastatic Colorectal Cancer

Chi M Nguyen, Paul G Yeh, Mai P Nguyen, et al. Cancer Res Commun. 2025 Oct 1;5(10):1852-1864

Colorectal cancer is a leading cause of cancer-related death and among the costliest cancers to treat in the United States. This study highlights the substantial economic burden of mCRC, with medical and prescription costs nearly twice those of nonmetastatic cases. Among 25,169 patients, 32.8% had metastasis at diagnos... Read More

15 Apr, 2026

Estimating Productivity Loss from Breast and Non-Small-Cell Lung Cancer among Working-Age Patients and Unpaid Caregivers: A Survey Study Using the Multiplier Method

Kevin Chiu, Joanna P MacEwan, Suepattra G May, et al. MDM Policy Pract. 2022 Aug 3;7(2)

Cancer can have a profound impact on productivity. Traditional approaches to capturing health-related productivity loss focus only on the foregone wages of affected patients, overlooking the losses caregivers can incur. This study estimated the burden of productivity loss among breast cancer (BC) and non-small-cell lun... Read More

15 Apr, 2026

Financial Toxicity Among Patients with Breast Cancer Worldwide: A Systematic Review and Meta-analysis

Ana N Ehsan, Catherine A Wu, Alexandra Minasian, et al. JAMA Netw Open. 2023 Feb 1;6(2):e2255388

Financial toxicity (FT) is the negative impact of cost of care on financial well-being. Patients with breast cancer are at risk for incurring high out-of-pocket costs given the long-term need for multidisciplinary care and expensive treatments. A comprehensive database search was conducted. Of the 11 086 articles retri... Read More

15 Apr, 2026

Estimated Out of Pocket Costs for Patients With Common Cancers & Private Insurance

Liam Rose, Ganesh Rajasekar, Anjali Nambiar, et al. JAMA Netw Open. 2025 Jul 1;8(7):e2521575

Cancer imposes a substantial economic burden on patients that may be worse in patients with higher-stage disease due to the need for more therapy.  The cohort consisted of 46,158 patients (mean age at diagnosis, 46 years; 30,733 female [66.6%]; 2543 Asian [5.5%], 4114 Black [8.9%], 3590 Hispanic [7.8%], and 31 099... Read More

15 Apr, 2026